Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists

被引:17
|
作者
Jitsuoka, Makoto [1 ]
Tsukahara, Daisuke [1 ]
Ito, Sayaka [1 ]
Tanaka, Takeshi [1 ]
Takenaga, Norihiro [1 ]
Tokita, Shigeru [1 ]
Sato, Nagaaki [1 ]
机构
[1] Banyu Pharmaceut Co Ltd, Merck Res Labs, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan
关键词
histamine H-3 inverse agonist; spiro-isobenzofuranone; PET tracer; brain permeability;
D O I
10.1016/j.bmcl.2008.07.125
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Spiro-isobenzofuranones 1a and 1b were discovered as potent, selective, and brain-penetrable non-imidazole H-3 receptor inverse agonists. Our corporate sample collection was screened to identify 2a as a lead. Recognizing the right-hand portion of 2a as an essential pharmacophore, an extensive screen of the left-hand piperidine portion was carried out to yield the potent spiro-derivatives 2t-x. Spiro-isobenzofuranone 2x, the most potent among the derivatives, was converted to the corresponding amide 1a, which possessed dramatically improved H3 activity (IC50 = 0.72 nM; more than 20-fold improvement over 2x). Further elaboration led to the identification of 1b, a 5-methoxy derivative with an IC50 of 0.54 nM. Our studies demonstrated that derivatives 1a and 1b to be potent, selective, and brain-penetrable H-3 inverse agonists. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5101 / 5106
页数:6
相关论文
共 50 条
  • [31] Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms
    Esbenshade, TA
    Krueger, KM
    Yao, BB
    Witte, DG
    Estvander, BR
    Baranowski, JL
    Miller, TR
    Hancock, AA
    INFLAMMATION RESEARCH, 2006, 55 (Suppl 1) : S45 - S46
  • [32] Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists
    Roche, Olivier
    Nettekoven, Matthias
    Vifian, Walter
    Sarmiento, Rosa Maria Rodriguez
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4377 - 4379
  • [33] Synthesis and structure-activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H3 receptor inverse agonists
    Tao, Ming
    Aimone, Lisa D.
    Gruner, John A.
    Mathiasen, Joanne R.
    Huang, Zeqi
    Lyons, Jacquelyn
    Raddatz, Rita
    Hudkins, Robert L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1073 - 1077
  • [34] Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
    Riddy, Darren M.
    Cook, Anna E.
    Diepenhorst, Natalie A.
    Bosnyak, Sanja
    Brady, Ryan
    la Cour, Clotilde Mannoury
    Mocaer, Elisabeth
    Summers, Roger J.
    Charman, William N.
    Sexton, Patrick M.
    Christopoulos, Arthur
    Langmead, Christopher J.
    MOLECULAR PHARMACOLOGY, 2017, 91 (02) : 87 - 99
  • [35] New developments around histamine H3 receptor antagonists/inverse agonists: a patent review (2010-present)
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (01) : 89 - 111
  • [36] Synthesis and SAR of novel histamine H3 receptor antagonists
    Jesudason, Cynthia D.
    Beavers, Lisa S.
    Cramer, Jeffrey W.
    Dill, Joelle
    Finley, Don R.
    Lindsley, Craig W.
    Stevens, F. Craig
    Gadski, Robert A.
    Oldham, Samuel W.
    Pickard, R. Todd
    Siedem, Christopher S.
    Sindelar, Dana K.
    Singh, Ajay
    Watson, Brian M.
    Hipskind, Philip A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) : 3415 - 3418
  • [37] Histamine H3 receptor antagonists
    Tozer, MJ
    Kalindjian, SB
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (07) : 1045 - 1055
  • [38] Preclinical pursuit of enhanced safety of histamine H3 antagonists/inverse agonists for neuropsychiatric disease
    Esbenshade, T. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S11 - S12
  • [39] Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity
    Hudkins, Robert L.
    Aimone, Lisa D.
    Bailey, Thomas R.
    Bendesky, Robert J.
    Dandu, Reddeppa Reddy
    Dunn, Derek
    Gruner, John A.
    Josef, Kurt A.
    Lin, Yin-Guo
    Lyons, Jacquelyn
    Marcy, Val R.
    Mathiasen, Joanne R.
    Sundar, Babu G.
    Tao, Ming
    Zulli, Allison L.
    Raddatz, Rita
    Bacon, Edward R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5493 - 5497
  • [40] The histamine H3 receptor: from gene cloning to H3 receptor drugs
    Rob Leurs
    Remko A. Bakker
    Henk Timmerman
    Iwan J. P. de Esch
    Nature Reviews Drug Discovery, 2005, 4 : 107 - 120